Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
necessary upgrades of essential software were not delivered
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| St. Olavs Hospital | OTHER |
| SINTEF Health Research | OTHER |
Not provided
Not provided
Not provided
Not provided
To evaluate the feasibility of the Fraxinus Virtual Bronchoscope Navigation (VBN) System in the bronchoscopic access to target lesions. The study emphasizes the system“s efficacy in diagnostics of peripheral pulmonary lesions and the ease of use for the operator.
Multi-center study. The study explores Fraxinus which is an open source, software only, simple guiding system for bronchoscopy. The system provides 3D maps with centerline-to-target information extracted from preoperative computed tomography. The ability of the system to guide a user to a peripheral target lesion will be evaluated. During bronchoscopy any established method for diagnostic sampling is allowed. User Evaluation will be essential to decide if the Fraxinus VBN System is beneficial in a clinical setting.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fraxinus VBN system | Device | Open source planning tool for bronchoscopy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Evidence if the Fraxinus VBN System has a role in the assessment of peripheral pulmonary lesions | The proportion of cases in which the use of the system is considered beneficial | 48 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic yield | Diagnostic success defined as cytology or biopsy with pathology | 1 week |
| Duration of procedure | Time spent with preparations and bronchoscopy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patents with undiagnosed peripheral pulmonary lesion(s) who have been recommended for bronchoscopy
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hanne Sorger, md phd | Norwegian University of Science and Technology | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St Olavs Hospital | Trondheim | Norway |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001984 | Bronchial Neoplasms |
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
| 48 hours |
| Adverse events | Procedure related adverse events or unexpected incidents registrated | 48 hours |
| Operators-reported satisfaction | Enquiry on main operator“s experience after end of bronchoscopy | 48 hours |
| D009369 |
| Neoplasms |
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |